Levin Capital Strategies’s T2 Biosystems, Inc TTOO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7
| Closed | -$4K | – | 265 |
|
|
2022
Q3 | $4K | Hold |
7
| – | – | ﹤0.01% | 223 |
|
|
2022
Q2 | $5K | Sell |
7
-6
| -46% | -$4.29K | ﹤0.01% | 237 |
|
|
2022
Q1 | $33K | Sell |
13
-10
| -43% | -$25.4K | ﹤0.01% | 266 |
|
|
2021
Q4 | $59K | Buy |
23
+18
| +360% | +$46.2K | 0.01% | 310 |
|
|
2021
Q3 | $21K | Sell |
5
-22
| -81% | -$92.4K | ﹤0.01% | 320 |
|
|
2021
Q2 | $159K | Buy |
27
+11
| +69% | +$64.8K | 0.02% | 298 |
|
|
2021
Q1 | $127K | Sell |
16
-25
| -61% | -$198K | 0.01% | 281 |
|
|
2020
Q4 | $252K | Buy |
41
+21
| +105% | +$129K | 0.03% | 208 |
|
|
2020
Q3 | $134K | Buy |
20
+2
| +11% | +$13.4K | 0.02% | 239 |
|
|
2020
Q2 | $112K | Sell |
18
-7
| -28% | -$43.6K | 0.02% | 179 |
|
|
2020
Q1 | $80K | Sell |
25
-2
| -7% | -$6.4K | 0.01% | 162 |
|
|
2019
Q4 | $156K | Buy |
27
+12
| +80% | +$69.3K | 0.02% | 190 |
|
|
2019
Q3 | $184K | Buy |
15
+4
| +36% | +$49.1K | 0.02% | 176 |
|
|
2019
Q2 | $90K | Sell |
11
-4
| -27% | -$32.7K | 0.01% | 199 |
|
|
2019
Q1 | $197K | Sell |
15
-5
| -25% | -$65.7K | 0.02% | 172 |
|
|
2018
Q4 | $301K | Buy |
20
+5
| +33% | +$75.3K | 0.01% | 198 |
|
|
2018
Q3 | $566K | Sell |
15
-3
| -17% | -$113K | 0.01% | 176 |
|
|
2018
Q2 | $698K | Buy |
+18
| New | +$698K | 0.01% | 167 |
|